InsidersTradesSigma
Browse the full record of transactions filed by Sofia Michael J., Dirigeant. Officer active across 1 companies, notably Arbutus Biopharma Corp. Cumulatively, 2 disclosures have been logged. Total volume traded: €1.8m. The latest transaction was disclosed on 1 December 2021 — Cession. Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations
Michael J. Sofia is the Chief Scientific Officer at Arbutus Biopharma Corp. In this role, he is responsible for leading the company's research and development efforts, which focus on antiviral treatments. Sofia plays a key role in scientific innovation and the development of new therapies.